Navigation Links
Adult Stem Cells Help Those With Immune Disorders, Heart Disease
Date:2/26/2008

Analysis of studies finds modest benefit with both conditions

TUESDAY, Feb. 26 (HealthDay News) -- Treatment with adult stem cells harvested from blood or bone marrow may benefit some patients with certain kinds of cardiovascular disorders and autoimmune diseases, a new U.S. analysis shows.

There are two types of stem cells, according to background information in the study. Embryonic stem cells are harvested from embryos four to five days after fertilization. Adult stem cells are located in tissues throughout the body and provide a reservoir for replacement of damaged or aging cells.

While stem cell therapy shows great promise, "clinical application has lagged due to ethical concerns [over embryonic stem cells] or difficulties harvesting or safely and efficiently expanding sufficient quantities," the review authors noted. "In contrast, clinical indications for blood-derived [from peripheral or umbilical cord blood] and bone marrow-derived stem cells, which can be easily and safely harvested, are rapidly increasing."

Dr. Richard K. Burt, of the Northwestern University Feinberg School of Medicine, and colleagues examined hundreds of studies of blood- or bone-marrow derived stem cells that were conducted between January 1997 and December 2007 -- 323 assessed feasibility and toxicity, and 69 looked at patient outcomes.

The review found that in 26 studies involving a total of 854 patients with autoimmune diseases there was a treatment-related death rate of: less than 1 percent (two of 220 patients) for nonmyeloablative (not causing bone marrow suppression); less than 2 percent (three of 197 patients) for dose-reduced myeloablative; and 13 percent (13 of 100 patients) for intense myeloablative regimens -- those including total body irradiation or high-dose busulfan, a drug used to treat some forms of chronic leukemia.

"While all trials performed during the inflammatory stage of autoimmune disease suggested that the transplantation of hematopoietic [formation of blood or blood cells] stem cells [HSCs] may have a potent disease-remitting effect, remission duration remains unclear, and no randomized trials have been published," the review authors wrote.

In 17 studies of 1,002 heart attack patients, 16 studies of 493 patients with chronic coronary artery disease, and three meta-analyses, there was evidence suggesting that adult stem cell transplantation may help lead to modest improvements in cardiac function among people with coronary artery disease.

More clinical trials are needed to determine the most appropriate stem cell type, dose, method, timing of delivery -- as well as adverse effects -- to treat cardiovascular and immune diseases and other disorders, the review authors concluded.

The study is published in the Feb. 27 issue of the Journal of the American Medical Association.

More information

The U.S. National Institutes of Health has more about stem cells.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Feb. 26, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. A rare diagnosis in the operation room: Kidney atrophy due to duplicated colon in an adult
2. Cognitive Impairment Declining in Older Adults
3. CME LLC Offers Education to Help Medical Professionals Better Recognize Adult ADHD
4. Hand-held computers prod older adults to exercise more, Stanford study shows
5. JDRF partners with Plureon to explore generating insulin-producing cells from adult stem cells
6. Modified Atkins diet can cut epileptic seizures in adults
7. Anti-Inflammatory Drug Improves Glycemia, Lowers Inflammation in Obese, Young Adults
8. Teens, Young Adults Missing Out on Latest Cancer Advances
9. Turning on adult stem cells may help repair bone
10. Adult stem cell application effective in treatment of peripheric vascular disease
11. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Adult Stem Cells Help Those With Immune Disorders, Heart Disease
(Date:5/28/2016)... ... 2016 , ... After a year and a half of planning the Multiple Pathways of ... Multiple Pathways of Recovery Conference was held May 2 -4, 2016 at the Mystic ... came together to explore the many pathways individuals use to get into and sustain their ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue ... Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields ... Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health ...
(Date:5/27/2016)... ... , ... This campaign aims to provide a path to improved education and ... and change. , As nearly 795,000 Americans suffering from a new or recurrent stoke ... with an estimated 129,000 of these people dying from stroke, it’s become our nation’s ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the ... for an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center ... Market Committee (FOMC) dot charts are of interest to the press for their noise ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... PUNE, India , May 27, 2016 ... in the instances of hypertension is driving ambulatory blood ... muscles lose their elasticity and their ability to respond ... blood pressure. This condition can lead to various cardiovascular ... and peripheral vascular disease. These diseases are growing in ...
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: